Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

  • Date

    Wednesday, March 10, 2021
    6:00 – 8:45 pm (Central Time Zone)

  • Location

    Live Webinar
    Instructions for joining will be sent the week of March 1, 2021.

  • Fee

    $20.00
    Registration Closed

    Please note: The registration form will be unavailable between 4:30 and 5:30 PM CST, Thursday, January 28th, 2021.

Target Audience

Pharmacists, physicians, and other health care professionals who care for patients with infectious diseases.

Program Description

Health care professionals need accurate and current information on the existing strategies to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). The present-day epidemiology and changing patterns of multidrug-resistant (MDR) Gram-negative pathogens further challenge the recognition of high-risk patient populations with pneumonia. Several new antimicrobial agents have recently been approved by the United States Food and Drug Administration for the treatment of HABP and VABP in adult patients. This program will discuss the latest treatment strategies and novel therapies available for the management of HABP and VABP caused by MDR Gram-negative pathogens.

Registration

Registration Fee: $20.00
Registration Deadline:  Monday, March 8, 2021

Registration fee includes up to 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credits, or up to 2.0 contact hours of AMA PRA Category 1 Credit(s)™ continuing medical education. Handouts will be provided electronically for attendees to download and print before the live webinar.

Registration Now Open!

Acknowledgement

This activity is supported by an educational grant by Shionogi Inc.

Program Co-Chair and Moderator

Larry H. Danziger, PharmD, FIDSA
Professor, Department of Pharmacy Practice
Co-Director, Section of Infectious Diseases Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago

Program Co-Chair

Keith A. Rodvold, PharmD, FCCP, FIDSA
UIC Distinguished Professor
Co-Director, Section of Infectious Diseases Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago

Questions? Please Contact:
Jill Wilson
Director, Educational Programs and Business Development
Office of Continuing Education and Meeting Services
jrmiller@uic.edu
Phone: 312-413-1288
Fax: 312-996-0448